Status:
COMPLETED
Managing Cancer and Living Meaningfully (CALM) Therapy in Individuals Diagnosed With a Primary Brain Tumor
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Psychological distress affects many people diagnosed with a primary central nervous system tumor (CNST). Distress can include negative feelings such as anger, fear, or sadness. Researcher...
Detailed Description
Background: * Psychological distress is an emotional state experienced by primary central nervous system tumor (PCNST) patients throughout the illness trajectory. It can often be under identified in ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Subjects with histological or imaging confirmation of primary central nervous system tumor (PCNST) who are undergoing standard of care or experimental treatment.
- Adults (greater than or equal to 18 years of age) who are English-speaking
- Subjects who have a life expectancy of at least 3 months from time of study entry to allow for participation in the 3 required sessions.
- Subjects must be enrolled on the Neuro-Oncology Branch Natural History Study 16C0151.
- The ability of the subject to understand and the willingness to sign a written informed consent document as determined by the assessment of the treating physicians.
- EXCLUSION CRITERIA:
- Participants without access to a smartphone, computer, or tablet to complete remote sessions.
Exclusion
Key Trial Info
Start Date :
August 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2024
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04852302
Start Date
August 11 2021
End Date
June 6 2024
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892